Analysts weigh in on Clorox

|About: The Clorox Company (CLX)|By:, SA News Editor

Estimates on Clorox (CLX -2.6%) are being taken lower by investment firms after the company's FQ4 sales read came in light.

Credit Suisse stays with its Underperform stance, saying Clorox's organic sales will only grow in the low single-digits

B. Riley lowers its FY15 EPS guidance to $4.40, below the mid-point of Clorox's guidance.

Citigroup is taking the long view on Clorox to stick with a Buy rating despite the short-term profit hiccups.